Track Selectis Health's receivables ($1.4M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), GBCS shows a receivables of $1.4M. That compares with $3M in the prior-year period — down 53.2% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, GBCS's receivables is now $1.4M (was $3M) — a 53.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Selectis Health is outperforming or lagging.
Tracking GBCS's receivables over time shows whether Selectis Health is scaling, shrinking, or reshaping that part of the business. The current reading is $1.4M That compares with $3M in the prior-year period — down 53.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has Selectis Health's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $1.4M) with ownership activity and broader fundamentals.